What They Have in Common: Your Initial Experience During your first month on either medication, youll likely notice some similar changes: A Quieter Appetite: This is often the first thing people notice
Some people on GLP-1 drugs develop issues with the gallbladder, such as gallstones, which can cause digestive pain and changes in burping
Semaglutide base binds to and activates GLP-1 receptors in the pancreas and brain, triggering glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting a sustained feeling of fullness
Yes, although it's not officially mentioned as a main adverse effect, a lot of patients who take GLP-1 drugs, like Mounjaro, say they sometimes burp with an eggy smell
Chronic glucagon-like peptide-1 infusion sustains left ventricular function and prolongs survival in spontaneously hypertensive, heart failure prone rats
These two Peptides are often combined based on the fact that together they work way better than each on their own